Sam A Financials
| 009300 Stock | KRW 16,160 20.00 0.12% |
Sam |
Understanding current and past Sam A Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sam A's financial statements are interrelated, with each one affecting the others. For example, an increase in Sam A's assets may result in an increase in income on the income statement.
Please note, the presentation of Sam A's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sam A's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sam A's management manipulating its earnings.
Sam A Stock Summary
Sam A competes with DB Insurance, Total Soft, Shinhan Financial, Pureun Mutual, and KB Financial. Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7009300005 |
| Business Address | SAMA Building, Seoul, |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | www.samapharm.co.kr |
| Phone | 82 2 2056 7283 |
| Currency | KRW - South Korean Won |
You should never invest in Sam A without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sam Stock, because this is throwing your money away. Analyzing the key information contained in Sam A's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sam A Key Financial Ratios
Sam A's financial ratios allow both analysts and investors to convert raw data from Sam A's financial statements into concise, actionable information that can be used to evaluate the performance of Sam A over time and compare it to other companies across industries.| Return On Equity | 6.38 | |||
| Return On Asset | 0.0117 | |||
| Number Of Employees | 287 | |||
| Beta | 0.63 | |||
| Z Score | 42.6 |
Sam Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sam A's current stock value. Our valuation model uses many indicators to compare Sam A value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sam A competition to find correlations between indicators driving Sam A's intrinsic value. More Info.Sam A Pharm Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Sam A Pharm Co is about 545.05 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sam A by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sam A's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sam A Pharm Systematic Risk
Sam A's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sam A volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Sam A Pharm correlated with the market. If Beta is less than 0 Sam A generally moves in the opposite direction as compared to the market. If Sam A Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sam A Pharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sam A is generally in the same direction as the market. If Beta > 1 Sam A moves generally in the same direction as, but more than the movement of the benchmark.
Sam A March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sam A help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sam A Pharm Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sam A Pharm Co based on widely used predictive technical indicators. In general, we focus on analyzing Sam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sam A's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0302 | |||
| Maximum Drawdown | 5.43 | |||
| Value At Risk | (1.67) | |||
| Potential Upside | 1.92 |
Complementary Tools for Sam Stock analysis
When running Sam A's price analysis, check to measure Sam A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam A is operating at the current time. Most of Sam A's value examination focuses on studying past and present price action to predict the probability of Sam A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam A's price. Additionally, you may evaluate how the addition of Sam A to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |